Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Executive Appointment

8 Feb 2005 07:00

Torex Retail PLC08 February 2005 8 February 2005 Torex Retail Appoints New CEO Torex Retail plc, the UK market leader in retail systems, is pleased to announcea significant strengthening of the executive management team. Chris Moore has been appointed as Chief Executive Officer with fullresponsibility for all executive matters. Mark Pearman will remain a key memberof the Executive Board assuming full responsibility for business development.The Company's ambitious growth plans will be spearheaded by Mark on a globalbasis through a combination of organic and acquisitive means. Rob Loosemore, Executive Chairman of Torex Retail, said: "We are delighted with these changes as we can now look forward to the immensebenefits of Chris' operational skills and Mark's ability to effect the longerterm growth of the company. We are a proven team and with our collective vigour, especially in the area oftechnology and innovation, we remain dedicated to delivering to our shareholdersand customers alike." Chris Moore background: Chris Moore, currently non-executive Chairman of the retail IT services group XNCheckout, has extensive experience with over 20 years within the IT sector. Heled the team at Torex PLC from March 1996 to April 2004, where he built up thebusiness into a European market leader in healthcare information systems and anestablished force within Retail IT. During his time at Torex, the Group grewdramatically both organically and by acquisition, with the market capitalisationgrowing from £10m to £350m. He was previously appointed non-executive DeputyChairman of Torex Retail plc on 2 November 2004. -Ends- For further information, please contact: Robert Loosemore, Executive Chairman Chris Moore, Chief ExecutiveRichard Thompson, Finance DirectorTorex Retail plcTelephone: +44 (0) 870 050 9900 Seb Hoyle / Freida MooreCitigate Dewe RogersonTelephone: +44 (0) 20 7638 9571 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jun 20217:00 amRNSCompletion of phase 1 of new US facility expansion
23rd Jun 20216:08 pmRNSDirector/PDMR Shareholding
10th Jun 20214:17 pmRNSHolding(s) in Company
3rd Jun 20211:37 pmRNSResult of AGM
11th May 20217:00 amRNSDirector/PDMR Shareholding
10th May 202110:00 amRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSGrant of share options
29th Apr 20214:11 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSFinal Results and Notice of AGM
20th Apr 20211:07 pmRNSHolding(s) in Company
20th Apr 202112:10 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSNotice of Results
13th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:40 pmRNSSecond Price Monitoring Extn
1st Apr 20214:36 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSInitial phase of US facility expansion complete
26th Feb 20217:00 amRNSDirectorate Change
19th Feb 20213:52 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSMove to Electronic Reporting
8th Feb 20217:00 amRNSTrading Update
5th Feb 20214:40 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSAppointment of Chief Financial Officer
6th Jan 20213:58 pmRNSPDMR Dealings
5th Jan 20217:00 amRNSConfirmation of Board appointments
4th Jan 202111:26 amRNSHoldings in Company
24th Dec 202012:56 pmRNSIssue of Equity & Total Voting Rights Replacement
24th Dec 202011:15 amRNSHoldings in Company
23rd Dec 20209:51 amRNSIssue of Equity and Total Voting Rights
4th Dec 20207:00 amRNSBoard Changes
3rd Dec 20204:54 pmRNSHoldings in Company
2nd Dec 20207:00 amRNSFirst delivery of OrthoPure® XT
27th Nov 20209:09 amRNSHoldings in Company
26th Nov 20204:02 pmRNSHoldings in Company
17th Nov 20207:00 amRNSAppointment of CEO
6th Nov 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSChange of Registered Office
26th Oct 20204:50 pmRNSHoldings in Company
7th Oct 20201:50 pmEQSHardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
28th Sep 202012:24 pmRNSHoldings in Company
16th Sep 20207:42 amRNSHoldings in Company
15th Sep 20204:40 pmRNSSecond Price Monitoring Extn
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20205:33 pmRNSHoldings in Company
2nd Sep 20207:00 amRNSUnaudited Interim Results
27th Aug 20207:00 amRNSNotice of Interim Results & Investor Presentation
24th Aug 20207:00 amRNSUK distribution partner for OrthoPure® XT
18th Aug 202011:27 amRNSHoldings in Company
17th Aug 20207:00 amRNSRelocation of UK office and manufacturing facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.